-
-
-
-
-
-
-
Vera Therapeutics (VERA) PT Lowered to $80 at Goldman Sachs
-
-
-
-
-
-
-
FDA grants accelerated approval to Vera Therapeutics' kidney drug
-
-
-
-
-
-
-
Vera Therapeutics, Inc. (VERA) Misses Q1 EPS by 36c
-
-
-
-
-
-
-
Vera Therapeutics (VERA) PT Raised to $66 at BofA Securities
-
-
-
-
-
-
-
Vera Therapeutics (VERA) PT Raised to $90 at H.C. Wainwright
-
-
-
-
-
-
-
Wolfe Research Downgrades Vera Therapeutics (VERA) to Peerperform
-
-
-
-
-
-
-
Vera Therapeutics (VERA) PT Raised to $85 at H.C. Wainwright
-
468,196 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

